STOCKS TELEGRAPH

Tag: PHG stock

  • Positive After-Hours Momentum In Philips (PHG) Stock

    Positive After-Hours Momentum In Philips (PHG) Stock

    Koninklijke Philips (NYSE: PHG) experienced a notable uptrend during the extended trading session on Friday, registering a 4.35% increase and reaching $23.75. This positive movement countered the earlier 0.83% dip observed in Philips stock during the regular trading hours, ultimately closing at $22.76. The surge in PHG stock was attributed to the introduction of a new product.

    Philips (PHG) unveiled its latest addition to the Philips Norelco OneBlade series, known as Philips Norelco OneBlade Intimate. Distinguished as the inaugural tool in the Philips Norelco portfolio that caters to both genders, it is specifically designed to safeguard even the most delicate pubic and armpit skin, ensuring a convenient and comfortable trimming or shaving experience. This meticulously crafted tool addresses the grooming needs of individuals with intimate care requirements.

    The development of Philips Norelco OneBlade Intimate is a culmination of years of feedback from both men and women, incorporating insights into their grooming preferences and experiences with existing Philips Norelco OneBlade products. Having sold over 100 million units since its initial launch in 2016, this innovation underscores the brand’s dedication to inclusivity and responsiveness to the growing demand for gender-inclusive grooming products that deliver both effectiveness and affordability.

    PHG is witnessing a transformation in personal care practices, challenging outdated gender norms. Consequently, gender neutrality is gaining prominence in the grooming industry. This shift prompted Philips to enhance its portfolio with an innovative product that caters to the grooming needs of everyone, irrespective of the user’s gender.

    In addition to these features, the product offers a quick cutter that efficiently trims hair at a remarkable speed of 100x per second, whether used on wet or dry hair. The slimmer handle design, compared to other OneBlade models, enhances maneuverability, enabling the tool to smoothly navigate curves and reach challenging areas with ease. Overall, Philips Norelco OneBlade Intimate incorporates a range of features to ensure optimal ease of use, making it a versatile and user-friendly grooming tool.

  • Philips (PHG) Trended Upward After Earnings Release

    Philips (PHG) Trended Upward After Earnings Release

    Koninklijke Philips N.V. (NYSE: PHG) experienced a notable ascent of 3.18%, reaching a valuation of $18.83 during its latest trading session. Furthermore, the trading volume of Philips (PHG) shares experienced a substantial surge, totaling 2.2 million shares on that day, surpassing the typical daily average of 1.12 million shares. This upswing in Philips’ stock value followed the release of its quarterly financial results.

    In the third quarter of 2023, the Group’s sales for PHG demonstrated an impressive year-over-year increase of 11%, reaching EUR 4.5 billion. Concurrently, income from operations stood at EUR 224 million, a significant turnaround from the EUR 1,529 million loss incurred in the same period of 2022. Philips reported a substantial adjusted EBITA growth, achieving EUR 457 million, equivalent to 10.2% of its sales. In the analogous quarter from the preceding year, this figure was EUR 209 million, representing 4.8% of sales.

    Nevertheless, Philips experienced a dip in comparable order intake, declining by -9% in comparison to the order bookings during the corresponding quarter of the previous year. This was predominantly attributed to a challenging comparison base stemming from exceptionally high levels in 2021, decreased orders from China, and extended order lead times.

    Philips managed to maintain a commendable improvement in its operating cash flow, amassing EUR 489 million, a significant improvement compared to the outflow of EUR 180 million in the same quarter of the prior year. PHG’s focal point remains on executing strategies to bolster patient safety, elevate quality standards, enhance supply chain reliability, and establish a more streamlined operational model.

    The highest priority in its agenda remains the completion of the Philips Respironics recall, with the remediation of sleep therapy devices almost reaching its conclusion, while the rectification of ventilators is an ongoing process. Furthermore, Philips introduced its innovative Image Guided Therapy Mobile C-arm System 3000, renowned for its workflow-enhancing attributes and exceptional image quality. This technological advancement empowers surgeons to deliver superior care to a larger patient demographic, offering a solution to the staff shortages prevalent in many healthcare facilities.

    In a move aimed at the Japanese market, PHG launched its ambulatory monitoring offering, a synergy of Philips ePatch Holter monitors with AI-driven ECG analysis and advanced algorithms. This pioneering approach seeks to alleviate the workload of clinicians and enhance the overall patient experience.

  • Q4 2021 Financial Update: Koninklijke Philips N.V. (PHG) stock Nosedives Premarket

    Q4 2021 Financial Update: Koninklijke Philips N.V. (PHG) stock Nosedives Premarket

    On January 12, Koninklijke Philips N.V. (PHG) disclosed updates on its fourth quarter and full-year 2021 financial results. Consequently, the stock nosedived in the premarket session to trade at $33.09 apiece, at the last check.

    In the previous market session, PHG stock added a small value of 1.15% at its close of $38.77. Following the announcement, the stock had lost a huge 14.65% in the premarket at the time of writing.

    The technology company, Koninklijke Philips N.V. works in the healthcare, lighting, and consumer well-being markets. Currently, the Netherlands-based company has a market capitalization of $33.15 billion with its 883.9M shares outstanding.

    PHG’s Q4 and FY2021 Financial Performance

    According to today’s announcement, PHG expects EUR 4.9 billion (approx.) in group sales for the fourth quarter of 2021. This is lower than the company’s previous expectations. Hence, this marks a comparable sales decrease of 10%. Further, the reason for this decrease is global supply chain shortages in addition to the postponement of customer equipment installations. Moreover, the previously announced Philips Respironics recall was also a major reason for the decline.

    Added to this, the sale decline and higher supply costs have led the expected group adjusted EBITA to be EUR 650 million approx. (13% of sales) for the Q4 2021.

    Resultantly, the expected full-year 2021 group sales are now EUR 17.2 billion approx., marking a comparable sales decline of 1%.

    In addition, PHG expects a full-year 2021 adjusted group EBITA of around EUR 2.1 billion (12% of sales approx.).

    Furthermore, the company intends to declare the complete financial results for the fourth quarter and full-year 2021 on January 24, 2022.

    Cancellation of 33.5M Shares

    On December 29, the company announced the completion of the cancellation of its 33.5 million shares. Currently, the company’s issued share capital amounts to EUR 176,7779,793.80 for its 883,898,969 common shares.

    The canceled shares of PHG included:

    • 20.5 million shares under the completed EUR 1.5 billion shares repurchase program started in Q1 2019.
    • 13.0 million shares under the ongoing EUR 1.5 billion buyback program announced in July 2021.

    PHG’s Partnership with IJsselland Hospital

    On December 29, a 12-year strategic partnership with IJsselland Hospital was announced by the company. According to the partnership, PHG will work on improving the care for patients as well as care providers in the hospital and its vicinity. With a focus on innovation, digitalization, and optimization, the collaboration also includes the purchase of systems and solutions like CT and MRI.